AtriCure Reports Strong Preliminary 2025 Results, Positive 2026 Outlook, and Improved Credit Facility Terms
Summary
AtriCure, Inc. announced strong preliminary Q4 and full-year 2025 financial results, provided positive 2026 guidance including anticipated net income, and secured more favorable terms for its $125M credit facility.
Key Events
-
Strong Preliminary 2025 Financial Performance
Reported preliminary Q4 2025 revenue of $140.5 million (13% growth over Q4 2024) and full-year 2025 revenue of $534.5 million (15% growth over FY 2024), with positive adjusted EBITDA of $57 million to $59 million.
-
Positive 2026 Financial Guidance
Projected 2026 revenue of $600 million to $610 million (12%-14% growth over FY 2025), increased adjusted EBITDA of $80 million to $82 million, and anticipated full-year net income.
-
Enhanced Credit Facility Terms
Amended its $125 million asset-based revolving credit facility, extending the term by three years, reducing overall interest rates, and removing the minimum utilization financial covenant, improving financial flexibility.
-
Solid Liquidity
Ended 2025 with approximately $167 million in cash and investments.
Analysis
AtriCure, Inc. delivered robust preliminary financial results for the fourth quarter and full year 2025, demonstrating strong revenue growth and positive adjusted EBITDA. The company's outlook for 2026 is particularly notable, projecting continued double-digit revenue growth and a significant shift to full-year net income, alongside sustained positive cash flow. This positive financial trajectory is further bolstered by the successful amendment of its $125 million asset-based revolving credit facility. The amendment extends the facility's term by three years, reduces interest rates, and removes a restrictive minimum utilization covenant, providing enhanced financial flexibility and a lower cost of capital. These developments, occurring while the stock trades near its 52-week high, signal strong operational execution and a strengthening financial foundation.
At the time of this filing, ATRC was trading at $41.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $28.29 to $43.18. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.